Essential role of PKC[delta] in apoptosis induction of mouse thymocytes.
Subject: Protein kinases (Research)
Apoptosis (Research)
Phorbol esters (Research)
Authors: Lutz-Nicoladoni, C.
Letschka, T.
Leitges, M.
Villunger, A.
Baier, G.
Pub Date: 01/01/2005
Publication: Name: American Journal of Immunology Publisher: Science Publications Audience: Professional Format: Magazine/Journal Subject: Biological sciences Copyright: COPYRIGHT 2005 Science Publications ISSN: 1553-619X
Issue: Date: Jan, 2005 Source Volume: 1 Source Issue: 1
Topic: Event Code: 310 Science & research
Accession Number: 145390345
Full Text: Abstract: The family of protein kinases C (PKCs) has been implicated in signal transmission leading to apoptosis induction and/or survival. These effects are cell type and tissue dependent. Numerous studies employing phorbol ester, a pleiotropic PKC activator, strongly implicated PKC in apoptosis induction of thymocytes. However, phorbol esters activate both, the conventional PKCs (PKC[alpha], [beta], [gamma]) as well as the novel PKCs ([delta], [epsilon], [eta] and [theta]), the PKC isotype(s) selectively involved in this process have not been established. In this study we used selective pharmacological PKC inhibitors and our established set of PKC knockout mice to define the PKC isotype that is involved in cell death induction of thymocytes. Pharmacological inhibition of nPKCs and in particular gene ablation of PKC[delta], results in a profound reduction of p53-dependent as well as independent apoptosis induction. In strict contrast, loss of conventional PKCs as well as loss of two other thymocyte-expressed nPKC family members, PKC[epsilon] and PKC[theta], does not significantly affect thymocyte apoptosis. Taken together, we define an essential and non-redundant pro-apoptotic role of PKC[delta] in regulating distinct signaling mechanisms that are required to provoke apoptosis of mouse double positive thymocytes in vitro.

Key words: Phorbol esters, PKC isotypes, thymocytes, apoptosis induction

INTRODUCTION

Protein kinase Cs (PKCs) are members of the serine/threonine protein kinase family, originally identified by Nishizuka and colleagues in 1977 as cyclic nucleotide-independent kinases [1]. Members of the PKC family have been implicated in numerous cell responses including cell growth and differentiation, cell cycle control, homeostasis, synaptic transmission, ion fluxes, secretion and tumorigenesis of a wide range of cell types and tissues [2]. According to their molecular structure and cofactor dependency they are classified into conventional PKCs (cPKCs) PKC[alpha], [beta], [gamma], novel PKCs (nPKCs) PKC[delta], [epsilon], [eta], [theta] and atypical PKCs (aPKCs) PKC[zeta] and PKC[iota]. cPKCs require [Ca.sup.2+] and diacylglycerol for activation, nPKCs are [Ca.sup.2+] independent and aPKCs neither require [Ca.sup.2+] nor diacylglycerol. Some of the isotypes exist as different splice variants [3]. All PKC isotypes listed, except PKC[gamma] are expressed in T cells. Among them PKC[alpha], PKC[delta], PKC[epsilon] and PKC[theta] are highly expressed [4]. PKCs are known to phosphorylate several cellular proteins, leading to modulation of surface antigens, activation of other protein kinases and induction of several key transcription factors, including aberrant signalling responses contributing towards malignant transformation [5].

Apoptosis or programmed cell death is a physiological process during thymic development. Thymic selection of immature T cells occurs at [CD4.sup.+][CD8.sup.+] double positive (DP) stage [6,7]. Only clones that will recognize foreign antigens associated with self-MHC molecules are positively selected to survive and differentiate into [CD4.sup.+] or [CD8.sup.+] single positive (SP) T cells (positive selection) [8,9]. On the other hand a high avidity T cell receptor (TCR) interaction promotes apoptosis of developing thymocytes (negative selection) [8-10]. Both, positive as well as negative selection, depend on direct cell-cell interactions between DP thymocytes and thymic stroma cells. However it is still unclear which intracellular signaling pathways are responsible for thymic selection. Deregulation of apoptosis is a hallmark of many diseases such as lymphoid cancers as well as autoimmunity [11].

The process of apoptosis is regulated at several levels through phosphorylation by many different protein kinases. The PKC family has been shown to exert both inhibitory and stimulatory influences, depending on cell type and stimulus for apoptosis induction. Generally, PKC[alpha], [beta], [epsilon] as well as atypical PKC isotypes are considered to be involved in antiapoptotic pathways, whereas PKC[delta] and PKC[theta] are considered to be involved in promotion of cell death [12]. Previous studies with mouse thymocytes and phorbol esters, pleiotropic PKC activators, however, revealed controversial results: DNA fragmentation induced by calcium ionophore or glucocorticoids in thymocytes was abrogated by phorbol ester treatment, indicating an anti-apoptotic role of PKCs [13]. On the other hand, phorbol ester treatment in thymocytes was shown to enhance apoptosis induced by tyrosine-kinase inhibitors, implying that PKC promotes apoptosis [14]. More recent studies, mostly using PKC specific pharmacological inhibitors, revealed both, an anti-apoptotic and a proapoptotic role of PKC isotypes in thymocytes. Simon and co-workers suggested PKC[epsilon] as a negative regulator of negative selection of DP thymocytes [15]. Consistently, phorbol ester was also found to prevent immature thymocytes from spontaneous as well as glucocorticoid-induced apoptosis [16,17]. On the other hand the activation of nPKCs, especially the PKC[theta] isotype, was suggested to promote a pathway for negative selection [18,19]. Along this line, a positive involvement of PKCs in glucocorticoid-induced apoptosis [20] as well as a role of PKCs in peptide-specific cell death [21] was postulated.

This in part contradictionary nature of these results occurred primarily from the use of phorbol esters as PKC activators, because they stimulate both, cPKCs and nPKCs. Additionally, phorbol esters also target receptors other than PKC, a concept that has been largely ignored in the past. In this study we used selective PKC inhibitors and for the first time, our established set of PKC knock out mice to now genetically define the distinct PKC isotypes that are involved in apoptosis induction of thymocytes. To investigate the potential role of PKCs in different apoptosis pathways, we induced apoptosis employing various agents, namely phorbol-12,13-dibutyrate (PDBu) (role in apoptosis [22-26]), the calcium ionophore ionomycin [27], staurosporine, an inhibitor of phospholipid/[Ca.sup.2+] dependent kinases mediating mitochondrial dysfunction [28], dexamethasone, a glucocorticoid regulating T cell survival, growth and differentiation [29-31], concanavalin A, a mitogenic plant lectin that mimics the effects of high avidity TCR ligation [32] and two agents inducing DNA damage, camptothecin [33] and etoposide [34]. FasL, a protein belonging to the tumor necrosis factor (TNF) family of cytokines was used to induce the extrinsic death receptor apoptotic pathway [35]. Finally, apoptosis was also induced by TCR crosslinking via anti CD3.

MATERIALS AND METHODS

Mice: C57/B16 wild-type mice were obtained from the animal facility of the Medical University of Vienna, Himberg, Austria. For knock out studies mice lacking a specific PKC isotype, which have been described elsewhere (PKC[alpha] [36], PKC[delta] [37], PKC[theta] [38] and PKC[epsilon] [39]) were used. p53 knock out mice were provided from A. Villunger.

Genotyping of mice: DNA was extracted from adult tail tissue. Genotyping of the PKC[delta], PKC[epsilon] and PKC[theta] alleles was performed by southern blot analysis or PCR was described (PKC[delta]), (PKC[epsilon]), (PKC[theta]) [37,38,40]). The PKC[alpha] allele was genotyped by PCR using the primers PKC[alpha] 3' prime E2 (5'-CCT GGT GGC AAT GGG TGA TCT ACA C-3') and PKC[alpha] 5' prime E2 (5'-GAG CCC TTG GGT TTC AAG TAT AGA-3') [Pfeifhofer, unpublished data].

Preparation of thymocytes: Thymi were taken from 6- 8 week old mice. Cells were singularized by mashing the organ in a strainer and raising the cell suspension through a syringe three times. Cells were washed in RPMI medium (Sigma Aldrich) and used for the assay.

Apoptosis detection: Freshly isolated thymocytes were plated in 96-well plates at a density of 2.5x[10.sup.5] cells per well in a total volume of 200[micro]l in RPMI medium (Biochrom) supplemented with 10% heat-inactivated fetal calf serum, 2mM L-glutamine and 50 u [mL.sup.-1] penicillin/streptomycin (all from Biochrom). For some experiments cells were preincubated with distinct PKC inhibitors for 90 min prior to apoptosis induction. Go6850 and Go6976 were obtained from Calbiochem. The pan PKC LMW Inhibitor was obtained from Altana Pharma. Inhibitors were used at a concentration of 500nM. Apoptosis induction was performed by TCR crosslinking (10 [micro]g [mL.sup.-1] anti CD3 2C11, precoated) +/- anti CD28 (1 [micro]g [mL.sup.-1]) or by addition of either concanavalin A (10 [micro]g [mL.sup.-1]), phorbol-12,13-dibutyrate (1 [micro]g [mL.sup.-1]), ionomycin (1 [micro]g [mL.sup.-1]), camptothecin (1[micro]M), etoposide (10 [micro]g [mL.sup.-1]), dexamethasone (1nM), staurosporine (100nM) or FasL (100 ng [mL.sup.-1]) plus enhancer for FasL (1 [micro]g [mL.sup.-1]) for up to 72 h. FasL and enhancer for FasL were purchased from Alexis, anti CD28 from BD Pharmingen and all other agents were obtained from Sigma-Aldrich. Cells were harvested at time points between 10 and 72 h after apoptosis induction. Late apoptotic and necrotic cells were stained with propidium iodide (5 [micro]g [mL.sup.-1] in PBS). Percentage of viable cells was determined by FACS analysis employing the FACScan[TM] Cytometer (Becton Dickinson) and CellQuest[TM] software.

RESULTS

PKC inhibition selectively prevents phorbol ester induced apoptosis: In order to investigate the role of distinct PKC isotypes in apoptosis induction of mouse double positive thymocytes we induced apoptosis ex vivo in thymocytes derived from wild-type C57/Bl6 mice, which were preincubated with pan PKC LMWI, inhibiting both, the conventional PKCs, PKC[alpha] and PKC[beta], as well as the novel PKCs, PKC[delta], PKC[epsilon], PKC[theta] and PKC[eta] or DMSO as buffer control. Apoptosis was induced by various apoptosis inducing agents, as indicated. As result, we observed a strong protection of PDBu induced apoptosis in cells preincubated with the pan PKC LMWI (Fig. 1A). In contrast, PKC inhibition did not affect apoptosis induced by TCR crosslinking (Fig. 1B), concanavalin A (Fig. 1C), dexamethasone (Fig. 1D), ionomycin (Fig. 1E), staurosporine (Fig. 1F), camptothecin (Fig. 1G) or etoposide (Fig. 1H).

[FIGURE 1 OMITTED]

Essential role of novel PKC isotypes in phorbol ester induced apoptosis: To further investigate which isotype might be involved in phorbol ester induced apoptosis we treated wild-type thymocytes with different PKC inhibitors either inhibiting conventional and novel PKCs (Go6850 and pan PKC LMWI) or inhibiting selectively the conventional PKCs (Go6976). As result, both pan PKC LMWI prevented thymocytes from PDBu induced apoptosis while cPKC inhibition did not (Fig. 2). These data suggested a proapoptotic role of at least one of the novel PKCs, PKC[delta], PKC[epsilon], PKC[eta] or PKC[theta]. Furthermore and employing thymocytes derived from a p53-deficient mouse line, this proapoptotic action of nPKCs appears independent of p53 function (Fig. 3).

[FIGURES 2-3 OMITTED]

Proapoptotic role of PKC[delta] in apoptosis of mouse thymocytes: Consistent with the results obtained in studies with pharmacological PKC inhibitors, experiments with our established set of PKC knock out mice revealed a proapoptotic role of PKC[delta] in phorbol ester induced apoptosis of mouse thymocytes (Fig. 4A). Heterozygous PKC[[delta].sup.+/-] thymocytes demonstrated an intermediate phenotype. Importantly, thymocytes derived from our PKC[epsilon] or PKC[theta] deficient mice were indistinguishable from wild-type littermates (Fig. 4B and 4C). PKC[epsilon] or PKC[theta] deficiency also did not affect apoptosis induced by ionomycin, concanavalin A, dexamethasone, staurosporine, camptothecin, etoposide or TCR crosslinking (data not shown). As a representative member of the cPKC family, PKC[[alpha].sup.-/-] deficient thymocytes were tested as well. Consistently, with the data collected with experiments employing PKC inhibitors, we did not observe any effects in PKC[[alpha].sup.-/-] thymocytes in respect to apoptosis induction by PDBu (data not shown), as well as ionomycin, concanavalin A, dexamethasone, staurosporine, camptothecin, etoposide or TCR crosslinking (data not shown).

[FIGURE 4 OMITTED]

Interestingly, deficiency of PKC[delta] additionally protects thymocytes from apoptosis by TCR crosslinking (Fig. 5A and 5B), dexamethasone (Fig. 5C), FasL (Fig. 5D), staurosporine (Fig. 5E) and etoposide (Fig. 5F). No significant effect of PKC[delta] could be observed in cells treated with concanavalin A (Fig. 5G) and ionomycin (Fig. 5H).

[FIGURE 5 OMITTED]

DISCUSSION

Previous studies of the role of the PKC family in apoptosis induction of thymocytes led to very oppositional results due to the application of phorbol esters as PKC activators. Proapoptotic effects [14,18-21] as well as antiapoptotic effects [13,16,17] were suggested. Phorbol esters are known to activate both the conventional PKCs (PKC[alpha], [beta], [gamma]) as well as the novel PKC family members (PKC[delta], [epsilon], [eta], [theta]), making it impossible to define the exact functional roles of distinct PKC isotypes in cell survival and/or apoptosis.

In order to identify the exact PKC isotypes positively or negatively involved in apoptosis of primary mouse double positive thymocytes we used selective PKC inhibitors and observed a proapoptotic role of novel PKCs in PDBu induced apoptosis (Fig. 1A and Fig. 2). Beside developmental apoptosis, programmed cell death is necessary as a cellular stress response, for example to agents inducing DNA damage as well as for activation induced cell death. Here and in contrast, pharmacological PKC inhibition neither affected DNA damage induced apoptosis by etoposide or camptothecin nor glucocorticoid induced apoptosis by dexamethasone nor apoptosis induced by the ionophore ionomycin, by staurosporine, by concanavalin A or anti CD3 mediated TCR crosslinking (Fig.1B-H).

Using thymocytes from all available novel PKC knock out mice we demonstrated the involvement of PKC[delta] (Fig. 4A and Fig. 5, but neither PKC[epsilon] (Fig. 4B) nor PKC[theta] (Fig. 4C) in apoptosis induced by PDBu, dexamethasone, FasL, staurosporine or etoposide. In contrast to the results obtained employing the pan PKC LMWI, knock out studies revealed that PKC[delta] is involved in various apoptotic pathways and that the promotion of apoptosis is not restricted to phorbol ester induced apoptosis. Ionomycin and concanavalin A were in fact the only substances where we did not observe reduced apoptosis of PKC[[delta].sup.-/-] and PKC[[delta].sup.+/-] cells (Fig. 5). This difference between inhibitor and knock out studies most likely is due to the fact that there always remains a residual activity of PKC isotypes upon pharmacological inhibition whereas in the knock out studies, it does not.

Investigations of different cell types postulated an essential role of PKC[delta] in apoptosis induction. For example, PKC[delta] was found to be activated during spontaneous apoptosis of neutrophils [41,42], in ventricular myocytes under hypoglycemic conditions [43], in various cell types in respond to [H.sub.2][O.sub.2] [44,45], manganese containing compounds [46] and ceramide [47]. The extrinsic apoptotic pathways mediated by TNF-[alpha] and FasL were shown to result in activation of PKC[delta], too [48,49]. Also DNA damage by UV-radiation, ionizing radiation or etoposide is associated with PKC[delta] activation [50]. Along this line, inhibition of PKC[delta] was shown to protect various cell types from various apoptosis inducers, indicating that PKC[delta] acts as proapoptotic signaling molecule. As potential downstream effectors, proapoptotic BH3-only proteins are likely. Consistently, thymocytes from pumadeficient mice were shown to be resistant to phorbol ester induced apoptosis [51] and also demonstrated reduced apoptotic responses to stress stimuli as well as to staurosporine or glucocorticoid treatment. DNA damage and oncogenes activate the proapoptotic BH3- only protein puma via the Mdm2-p53 pathway, while PMA, ionomycin, staurosporine and dexamethasone lead to p53 independent activation of puma [51]. Along this line we demonstrated that the protection of PDBu induced apoptosis in cells preincubated with a pan PKC inhibitor is independent of p53 (Fig. 3).

Taken together, we thus establish a physiological and non-redundant proapoptotic role of PKC[delta] but not PKC[alpha], [epsilon] nor [theta] in apoptosis induction of mouse DP thymocytes.

ACKNOWLEDGMENT

This work was supported by grants of the FWF (P16229-B07 + SFB021) and by a cooperation agreement with Altana Pharma (Konstanz, Germany). We are grateful to Miriam Erlacher (from the Division for Pathophysiology, Innsbruck, Austria) for providing the [p53.sup.-/-] knock out mice. Thanks also to Drs. Christa Pfeifhofer, Thomas Gruber and Nikolaus Thuille (all from the Department for Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck, Austria) for the breeding of PKC[[alpha].sup.-/-], PKC[[epsilon].sup.-/-] and PKC[[theta].sup.-/-] mice. All experiments comply with the current laws of Austria.

Abbreviations: DMSO, dimethyl sulfoxide; DP, double positive; FACS, fluorescence activated cell sorter; FasL, Fas ligand; aPKCs, atypical PKCs; cPKCs, conventional PKCs; nPKCs, novel PKCs; pan PKC LMWI, pan PKC low molecular weight inhibitor; PDBu, phorbol-12,13-dibutyrate; PKC, protein kinase C, SD, standard deviation; SP, single positive; TCR, T cell receptor; TNF, tumor necrosis factor; VP16, Etoposide, wt, wild-type.

REFERENCES

[1.] Yamamoto, M., Y. Takai, Y., E. Hashimoto and Y. Nishizuka, 1977. Intrinsic activity of guanosine 3', 5'-monophosphate-dependent protein kinase similar to adenosine 3', 5'-monophosphatedependent protein kinase. I. Phoshorylation of histone fractions. J. Biochem. (Tokyo), 81: 1857-1862.

[2.] Parker, P.J. and J. Murray-Rust, 2004. PKC at a glance. J. of Cell Sci., 117: 131-132.

[3.] Kofler, K., M. Erdel, G. Utermann and G. Baier, 2002. Molecular genetics and structural genomics of the human protein kinase C gene module. Genome Biol., 3: 1-10.

[4.] Baier, G., 2003. The PKC gene module: Molecular biosystematics to resolve its T cell functions. Cell Immunol., 152: 271-278.

[5.] Berry, N. and Y. Nishizuka, 1990. Protein kinase C and T cell activation. Eur. J. Biochem., 189: 205-214.

[6.] Sha, W.C., C.A. Nelson, R.D. Newberry, D.M. Kranz, J.H. Russell and D.Y. Loh, 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature, 336: 73-76.

[7.] Teh, H.S., P. Kisielow, B. Scott, H. Kishi, Y. Uematsu, H. Bluthmann and H. von Boehmer, 1988. Thymic major histocompatibility complex antigens and the [alpha] [beta] T-cell receptor determine CD4/CD8 phenotype of T cells. Nature, 335: 229-233.

[8.] von Boehmer, H., 1994. Positive selection of lymphocytes. Cell, 76: 219-228.

[9.] Allen, P.M., 1994. Peptides in positive and negative selection: A delicate balance. Cell, 76: 593-596.

[10.] Surh, C.D. and J. Sprent, 1994: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature, 372: 100-103.

[11.] Antonsson, B. and J.-C. Martinou, 2000. Apoptosis in development. Exp. Cell Res., 256: 50-57.

[12.] Gutcher, I., P.R. Webb and N.G. Anderson, 2003. The isoform-specific regulation of apoptosis by protein kinase C. Cell. Mol. Life Sci., 60: 1061-1070.

[13.] McConckey, D.J.P. Hartzell, M. Jondal and S. Orrenius, 1989. Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J. Biol. Chem., 264: 13399-13402.

[14.] Azuma, Y., Y. Onishi, Y. Sato and H. Kizaki, 1993. Induction of mouse thymocyte apoptosis by inhibitors of tyrosine kinases is associated by dephosphoylation of nuclear proteins. Cell Imunol., 152: 271-278.

[15.] Simon, A.K., N. Auphan, M. Pophillat, C. Boyer, S. Ghosh, M. Rincon, R.A. Flavell and A.M. Schmitt- Verhulst, 2000. The lack of NF-kB transactication and PKCepsilon expression in CD4(+)CD8(+) thymocytes correlates with negative selection. Cell Death Differ., 7: 1253-1262.

[16.] Rennecke, J., K.H. Richter, S. Haussermann, L. Stempka, S. Strand, M. Stohr and F. Marks, 2000. Biphasic effect of protein kinase C activators on spontaneous and glucocorticoid-induced apoptosis in primary mouse thymocytes. Biochim. Biophys. Acta, 1497: 289-296.

[17.] Tanahashi, M., T. Yokoyama, Y. Kobayashi, Y. Yamakawa, M. Maeda and Y. Fujii, 2001. Effect of phorbol ester and calcium ionophore on human thymocytes. Hum. Immunol., 62: 771-781.

[18.] Asada, A., Y. Zhao, S. Kondo and M. Iwata, 1998. Induction of thymocyte apoptosis by [Ca.sup.2+]- independent protein kinase C (nPKC) activation and its regulation by calcineurin activation. J. Biol. Chem., 273: 28392-28398.

[19.] Asada, A., Y. Zhao, H. Komano, T. Kuwata, M. Mukai. K. Fujita, Y. Tozawa, R. Iseki, H. Tian, K. Sato, Y. Motegi, R. Suzki, M. Yokoyama and M. Iwata, 2000. The calcium-independent protein kinase C participates in an early process of CD3/CD28-mediated induction of thymocyte apoptosis. Immunology, 101: 308-315.

[20.] Cifone, M.G., G. Migliorati, R. Parroni, C. Marchetti, D. Millimaggi, A. Santoni and C. Riccardi, 1999. Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase and caspases. Blood, 93: 2282-2296.

[21.] Kong, Y.Y., K.D. Fischer, M.F. Bachmann, S. Mariathasan, I. Kozieradzki, M.P. Nghiem, D. Bouchard, A. Bernstein, P.S. Ohashi and J.M. Penninger, 1998. Vav regulates peptide-specific apoptosis in thymocytes. J. Exp. Med., 188: 2099- 2111.

[22.] Farrar, J.J., J. Fuller-Farrar, P.L. Simon, M.L. Hilfiker, B.M. Stadler, W.L. Farrar, 1980. Thymoma production of T cell growth factor (IL2). J. Immunol., 125: 2555-2558.

[23.] Furstenberger, G., D.L. Berry, B. Sorg and F. Marks, 1981: Skin tumour promotion by phorbol esters is a two-stage process. Proc. Nat. Acad. Sci, 78: 7722-7726.

[24.] Saitoh, T. and K.R. Dobkins, 1986. Protein kinase C in human brains and its inhibition by calmodulin. Brain Res., 379: 196-199.

[25.] Schmidt, R. and E. Hecker, 1975. Autooxitation of phorbol esters under normal storage conditions. Cancer Res., 35: 1375-1377.

[26.] Rebois, R.V. and L. Patel, 1985. Phorbol ester causes desensitization of gonadotropin-responsive adenylate cylase in a murine Leydig tumour cell line. J. Biol. Chem., 260: 8026-8031.

[27.] Toeplitz, B.K., 1979. J. Chem. Soc., 101: 3444.

[28.] Kruman, I., Q. Guo and M.P. Mattson, 1998. Calcium and reactive oxygen species mediate staurosporinee-induced mitochondrial dysfunction and apoptosis in PC12 cells. J. Neurosci. Res., 51: 293-308.

[29.] Riccardi, C., M.G. Cifone and G. Migliorati, 1999. Glucocorticoid hormone-induced modulation of gene expression and regulation of T-cell death: Role of GITR and GILZ, two dexamethasone-induced genes. Cell Death Differ., 6: 1182-1189.

[30.] Wershil, B.K., G.T. Furuta, J.A., Lavigne, A.R. Choudhury, Z.S. Wang and S.J. Galli, 1995. Dexamethasone and cyclosporin A supress mast cell-leukocyte cascades by multiple mechanisms. Int. Arch. Allergy Immunol., 107: 323-324.

[31.] Lavista Llanos, S. and A. Roldan, 1999. Effect of dexamethasone on nitric oxide (NO.) production by cultured astrocytes. Biocell., 23: 29-35.

[32.] Rudiger, H. and H.J. Gabius, 2001. Plant lectins: Occurrence, biochemistry, functions and applications. Glycoconj. J. , 18: 589-613.

[33.] Fan, Y., J.N. Weinstein, K.W. Kohn, L.M. Shi and Y. Pommier, 1998. Molecular modelling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin. J. Med. Chem., 41: 2216-2226.

[34.] Droin, N., L. Dubrez, B. Eymin, C. Renvoize, J. Breard, M.T. Dimanche-Boitrel and E. Solary, 1998. Upregulation of CASP genes in human tumour cells undergoing etoposide-induced apoptosis. Oncogene, 16: 2885-2894.

[35.] Wajant, H., 2002. The Fas signaling pathway: More than a paradigm. Science, 296: 1635-1636.

[36.] Leitges, M., M. Plomann, L. Standaert, G. Bandyopadhyay, M.P. Sajan, Y. Kanoh and R.V. Farese, 2002. Knockout of PKC[alpha] enhances insulin signaling through PI3K. Mol. Endocrinol., 16: 847- 858.

[37.] Leitges, M., M. Mayr, U. Braun, U. Mayr, C. Li, G. Pfister, N. Ghaffari-Tabrizi, G. Baier, Y. Hu and Q. Xu, 2001. Exacerbated vein graft arteriosclerosis in protein kinase C[delta]--null mice. J. Clin. Invest., 10: 1505-1512.

[38.] Pfeifhofer, C., K. Kofler, T. Gruber, N. Ghaffari- Tabrizi, C. Lutz, K. Maly, M. Leitges and G. Baier, 2003. Protein Kinase C[theta] Affects [Ca.sup.2+] Mobilization and NFAT Cell Activation in Primary Mouse T Cells. J. Exp. Med, 197, 11: 1525-1535.

[39.] Klein, G., A. Schaefer, D. Hilfiker-Kleiner, D. Oppermann, P. Shukla, A. Quint, E. Podewski, A. Hilfiker, F. Schroder, M. Leitges and H. Drexler, 2005. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKC[epsilon]. Circ. Res., 96: 748-755.

[40.] Gruber, T., N. Thuille, N. Hermann-Kleiter, M. Leitges and G. Baier, 2004. Protein kinase C[epsilon] is dispensable for TCR/CD3-signaling. Mol. Immunol., 42: 305-310.

[41.] Pongracz, J., P. Webb, K. Wang, E. Deacon, O.J. Lunn and J.M. Lord, 1999. Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C--[delta]. J. Biol. Chem., 274: 37329-37334.

[42.] Khwaja. A. and L. Tatton, 1999. Caspase-mediated proteolysis and activation of protein kinase C[delta] play a central role in neurophil apoptosis. Blood, 94: 291-301.

[43.] Shizukuda, Y., M.E. Reyland and P.M. Buttrick, 2002. Protein kinase C[delta] modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol., 282: 1625-1634.

[44.] Majumber, P.K., N.C. Mishra, X. Sun, A. Bharti, S. Kharbanda, S. Saxena and D. Kufe, 2001. Targeting of protein kinase C delta to mitochondria in oxidative stress response. Cell Growth Differ., 12: 465-470.

[45.] Konishi, H., E. Yamauchi, H. Taniguchi, T. Yamamoto, H. Matsuzaki, Y. Takemura, K. Ohmae, U. Kikkawa and Y. Nishizuka, 2001. Phosphorylation sites of protein kinase C delta in [H.sub.2][O.sub.2]-treated cells and its activation by tyrosine kinase in vitro. Proc. Natl. Acad. Sci. USA, 98: 6587-6592.

[46.] Anantharam, V., M. Kitazawa, J. Wagner, S. Kaul and A.G. Kanthasamy, 2002. Caspase 3--dependent proteolytic cleavage of protein kinase C[delta] is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J. Neurosci., 22: 1738-1751.

[47.] Kajimoto, T., S. Ohmori, Y. Shirai, N. Sakai and N. Saito, 2001. Subtype- specific translocation of the [delta] subtype of protein kinase C and its activation by tyrosine phosphorylation induced by ceramide in HeLa cells. Mol. Cell Biol., 21: 1769-1783.

[48.] Emoto Y., Y. Manome, G. Meinhardt, H. Kisaki, S. Kharbanda, M. Robertson, T. Ghayur, W.W. Wong, R. Kamen and R. Weichelbaum, 1995. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J., 14: 6148-6156.

[49.] Scheel-Toellner, D., D. Pilling, A.N. Akbar, D. Hardie, G. Lombardi, M. Salmon and J.M. Lord, 1999. Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta., Eur. J. Immunol., 29: 2603-2612.

[50.] Brodie, C. and P.M. Blumberg, 2003. Regulation of cell apoptosis by protein kinase C[delta]. Apoptosis, 8: 19-27.

[51.] Villunger, A., E.M. Michalak, L. Coultas, F. Muellauer, G. Boeck, M.J. Ausserlechner, J.M. Adams and A. Strasser, 2003. p53- and druginduced apoptotic responses mediated by BH3-only proteins puma and noxa. Science, 302: 1036-1038.

(1) Lutz-Nicoladoni, C., (1) Letschka, T., (2) Leitges, M. (3) Villunger, A and (1) Baier, G.

(1) Department for Medical Genetics, Molecular and Clinical Pharmacology Innsbruck Medical University, Austria

(2) Medical University, Hanover, Germany

Corresponding Author: Dr. Gottfried Baier, Innsbruck Medical University, Schoepfstrasse 41, A-6020 Innsbruck, Austria/Europe, Tel: +43 (512)/507-3451, Fax: +43 (512)/507-2861
Gale Copyright: Copyright 2005 Gale, Cengage Learning. All rights reserved.